Improving Survivorship Care for Older Adults After Chemotherapy
This study is looking at ways to improve care for older adults (65 and older) who have finished chemotherapy for cancer that aimed to cure them. Researchers want to see if adding a Geriatric Assessment Visit to a standard survivorship care plan helps improve your quality of life and satisfaction with your care. You might be able to join if you've completed chemotherapy with the goal of cure and are scheduled to receive a survivorship care plan. The study will measure how many people stay in the study, how long it takes to enroll everyone, and how acceptable the study is to participants. The study's current status is unclear.
- Study design
- This is a pilot randomized study, meaning participants are assigned by chance to different groups. It aims to enroll 70 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure outcomes like retention and acceptability between 4 to 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Survivorship Care for Older Adults After Chemotherapy
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Haifaa Abdulhaq, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Study retention rate4-6 months
Feasibility of the study will be assessed by study retention rate which is defined as proportion of enrolled participants who remain enrolled until study completion.
- Number of months needed for completion of trial enrollment4-6 months
- Acceptability of the study: survey4-6 months
Assess acceptability via a short survey administered to participating oncology nurse navigators and patients selected for the intervention group.